{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:50:34Z","timestamp":1782906634391,"version":"3.54.5"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["K24 DA034621-01"],"award-info":[{"award-number":["K24 DA034621-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2016,12,1]]},"DOI":"10.1093\/cid\/ciw579","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T20:18:20Z","timestamp":1471983500000},"page":"1479-1481","source":"Crossref","is-referenced-by-count":85,"title":["Efficacy and Safety of Sofosbuvir\/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials"],"prefix":"10.1093","volume":"63","author":[{"given":"Jason","family":"Grebely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Aspinall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Osinusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Brainard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Mani","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macky","family":"Natha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"2016111201323364000_63.11.1479.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.107"},{"key":"2016111201323364000_63.11.1479.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"2016111201323364000_63.11.1479.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"2016111201323364000_63.11.1479.4","unstructured":"AASLD \/IDSA. Recommendations for testing, managing, and treating hepatitis C. In; 2015. Available at: www.hcvguidelines.org\/. Accessed 1 September 2016."},{"key":"2016111201323364000_63.11.1479.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.07.005"},{"key":"2016111201323364000_63.11.1479.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"2016111201323364000_63.11.1479.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1007"},{"key":"2016111201323364000_63.11.1479.8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit306"},{"key":"2016111201323364000_63.11.1479.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ948"},{"key":"2016111201323364000_63.11.1479.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.029"},{"key":"2016111201323364000_63.11.1479.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw580"},{"key":"2016111201323364000_63.11.1479.12","doi-asserted-by":"crossref","unstructured":"Dore GJ , Altice F , Litwin AH et al . Elbasvir\/grazoprevir to treat HCV infection in persons receiving opioid agonist therapy: a randomized controlled trial (C-EDGE CO-STAR). Ann Intern Med 2016; doi:10.7326\/M16-0816 .","DOI":"10.7326\/M16-0816"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article\/63\/11\/1479\/2526222\/Efficacy-and-Safety-of-SofosbuvirVelpatasvir-in","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:14:32Z","timestamp":1498324472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/ciw579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,12]]},"published-print":{"date-parts":[[2016,12,1]]}},"alternative-id":["10.1093\/cid\/ciw579"],"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw579","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}